UPDATE: Morgan Stanley Upgrades Legand Biotech Corp. (LEGN) to Overweight
Tweet Send to a Friend
(Updated - January 31, 2022 5:24 AM EST)
Morgan Stanley analyst Matthew Harrison upgraded Legand Biotech Corp. (NASDAQ: LEGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Matthew Harrison upgraded Legand Biotech Corp. (NASDAQ: LEGN) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
